AstraZeneca (US.AZN) gets EU backing for targeted breast cancer therapies - 27 iunie 2022

De la TradeVille.ro wiki


 AstraZeneca said on Monday two of its existing therapies were recommended for treating patients with some forms of high-risk breast cancers in the European Union, in a boost to the company's oncology portfolio. 

 Enhertu is seen as a major growth driver for AstraZeneca, with some analysts expecting peaks sales of $10 billion. The drug is also expected to be cleared for patients with low levels of HER2 this month after the recent success of a trial.


https://www.reuters.com/business/healthcare-pharmaceuticals/two-astrazeneca-drugs-get-eu-backing-treatment-some-breast-cancers-2022-06-27/

https://finance.yahoo.com/news/1-astrazeneca-gets-eu-backing-074923024.html

Adus de la „https://wiki.tradeville.ro/index.php?title=AstraZeneca_(US.AZN)_gets_EU_backing_for_targeted_breast_cancer_therapies_-_27_iunie_2022&oldid=2536”